← Leaderboards
Myriam Heiman
Rockefeller University
$20,819,113
Attributed
$39,386,932
Total exposure
13
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.1M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,386,932 · 13
By mechanism
R01$16,571,621 · 6
U01$12,564,620 · 1
RF1$3,058,535 · 1
R35$2,155,114 · 1
P50$1,963,013 · 1
R61$1,629,825 · 1
Top collaborators
- Manolis Kellis17 shared
- Veronique Belzil5 shared
- Christopher James Donnelly5 shared
- Peter C Searson5 shared
- Veronica A Alvarez4 shared
Most similar at Rockefeller University
Same institution · by research overlap
- Jean-Laurent Casanova$36,806,361
- Jacinta Bustamante$1,271,250
- Hyung Jin Ahn$3,716,874
- Eleftherios Michailidis$3,717,575
- Qian Zhang$1,359,757
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMolecularCell TypeGenesPathway InteractionsNeuronsTherapeutic TargetPhenotypeAffectGenetic TranscriptionResponseNeurodegenerative DisordersMouse ModelIn VivoBrainResolutionTissuesAnimalsNew Therapeutic TargetCorpus Striatum StructureGeneticEpigenomicsGene ExpressionEnhancers
Grant awards (43)
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,610,459
U01 · FY2025 · DA
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$1,752,943
R01 · FY2025 · NS
Single-cell multi-region transcriptional and epigenomic dissection of VCID.$1,034,087
R01 · FY2025 · NS
Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain$616,630
R01 · FY2025 · DA · contact PI
Integration and Validation of Single-Cell Neuronal and Immune Molecular Responses in SUD and HIV$558,668
R01 · FY2025 · DA
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntingtonâs Disease$542,850
R35 · FY2025 · NS · contact PI
Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain$451,795
R33 · FY2025 · HL
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,610,459
U01 · FY2024 · DA
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$1,818,953
R01 · FY2024 · NS
Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain$616,630
R01 · FY2024 · DA · contact PI
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntingtonâs Disease$526,564
R35 · FY2024 · NS · contact PI
Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain$432,160
R33 · FY2024 · HL
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,433,874
U01 · FY2023 · DA
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$2,054,384
R01 · FY2023 · NS
Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain$616,630
R01 · FY2023 · DA · contact PI
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntingtonâs Disease$542,850
R35 · FY2023 · NS · contact PI
Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain$457,773
R33 · FY2023 · HL
Single-cell multi-region transcriptional and epigenomic dissection of VCID.$3,058,535
RF1 · FY2022 · NS
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,447,914
U01 · FY2022 · DA
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$1,662,271
R01 · FY2022 · NS
Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain$796,775
R61 · FY2022 · HL
Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain$616,630
R01 · FY2022 · DA · contact PI
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntingtonâs Disease$542,850
R35 · FY2022 · NS · contact PI
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,461,914
U01 · FY2021 · DA
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$1,817,770
R01 · FY2021 · NS
Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain$833,050
R61 · FY2021 · HL
Determinants of cell type-specific vulnerability in Huntington's disease$365,000
R01 · FY2021 · NS · contact PI
Determinants of cell type-specific vulnerability in Huntington's disease$35,313
R01 · FY2021 · NS · contact PI
Determinants of cell type-specific vulnerability in Huntington's disease$400,313
R01 · FY2020 · NS · contact PI
Determinants of cell type-specific vulnerability in Huntington's disease$400,313
R01 · FY2019 · NS · contact PI
Determinants of cell type-specific vulnerability in Huntington's disease$400,313
R01 · FY2018 · NS · contact PI
Determinants of cell type-specific vulnerability in Huntington's disease$400,313
R01 · FY2017 · NS · contact PI
Development of SLIC, a methodology for synthetic lethal screening in the CNS$354,000
R01 · FY2016 · NS · contact PI
Development of SLIC, a methodology for synthetic lethal screening in the CNS$354,000
R01 · FY2015 · NS · contact PI
Animal Core$451,934
P50 · FY2014 · MH · contact PI
Development of SLIC, a methodology for synthetic lethal screening in the CNS$350,460
R01 · FY2014 · NS · contact PI
Development of SLIC, a methodology for synthetic lethal screening in the CNS$346,000
R01 · FY2013 · NS · contact PI
Animal Core$315,867
P50 · FY2013 · MH · contact PI
Animal Core$329,029
P50 · FY2012 · MH · contact PI
Animal Core$451,934
P50 · FY2011 · MH · contact PI
Animal Core$414,249
P50 · FY2010 · MH · contact PI
Cell Specific Analysis of Psychostimulant Drug Action$52,048
F32 · FY2007 · DA · contact PI
Cell Specific Analysis of Psychostimulant Drug Action$50,428
F32 · FY2006 · DA · contact PI